| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/096120339500400303 |
| P698 | PubMed publication ID | 7655486 |
| P2093 | author name string | D P Symmons | |
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Rheumatic disease in Jamaica | Q33551951 | ||
| Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia | Q33552519 | ||
| Systemic lupus erythematosus in Zimbabwe | Q33556851 | ||
| Rheumatic disorders in Zimbabwe: a prospective analysis of patients attending a rheumatic diseases clinic | Q33562718 | ||
| Systemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation | Q33584094 | ||
| Frequency of systemic lupus erythematosus in different ethnic groups in hawaii | Q39886999 | ||
| The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. | Q46144184 | ||
| SLE in black S. Africans | Q46431054 | ||
| Autoimmune disease and parasitic infections in Nigerians | Q47934197 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 176-178 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Frequency of lupus in people of African origin | |
| P478 | volume | 4 |
| Q43850415 | Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype |
| Q34023782 | Autoimmunity and malaria: what are they doing together? |
| Q38014539 | Belimumab for the management of systemic lupus erythematosus |
| Q26796486 | Belimumab in systemic lupus erythematosus: a perspective review |
| Q47962688 | Can malaria trigger systemic lupus erythematosus? |
| Q33749895 | Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans |
| Q36350811 | Cigarette smoking and systemic lupus erythematosus: a smoking gun? |
| Q38618968 | Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study |
| Q33873329 | Cytokines and systemic lupus erythematosus |
| Q26749296 | Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools |
| Q35976956 | Digital gangrene as the initial presentation of systemic lupus erythematosus |
| Q34509018 | Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice |
| Q45074538 | Gut microbiota in human SLE and a mouse model of lupus |
| Q33696879 | Infection in systemic lupus erythematosus: friend or foe? |
| Q64109131 | Living with systemic lupus erythematosus in South Africa: a bitter pill to swallow |
| Q40868947 | Lupus around the world |
| Q44398366 | Lupus in Africa: can we dispel the myths and face the challenges? |
| Q34638296 | Lupus: an overview of the disease and management options |
| Q77719723 | Mucocutaneous disease in Arabs with systemic lupus erythematosus: clinical expression and relevance to autoantibodies |
| Q44621605 | Pathogenesis of autoimmune thyroid diseases |
| Q40396348 | Pattern of systemic lupus erythematosus among Nigerians |
| Q47697086 | Predictors and outcome of systemic lupus erythematosus (SLE) admission rates in a large teaching hospital in sub-Saharan Africa |
| Q26745015 | Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease |
| Q39429814 | Role of Natural IgM Autoantibodies (IgM-NAA) and IgM Anti-Leukocyte Antibodies (IgM-ALA) in Regulating Inflammation |
| Q26773130 | SLE: Another Autoimmune Disorder Influenced by Microbes and Diet? |
| Q36790796 | Sm antibodies increase risk of death in systemic lupus erythematosus |
| Q47889345 | Survival of patients with SLE admitted to an intensive care unit-a retrospective study |
| Q50961904 | Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. |
| Q33357929 | Systemic lupus erythematosus in Tunisia. A multicentric study. About 295 cases |
| Q93193261 | Systemic lupus erythematosus: Diagnosis and clinical management |
| Q38833876 | Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus |
| Q34111851 | The 'hygiene hypothesis' for autoimmune and allergic diseases: an update |
| Q36503803 | The United States to Africa lupus prevalence gradient revisited |
| Q37381684 | The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease |
| Q35148597 | The epidemiology of systemic lupus erythematosus |
| Q28082281 | Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications |
| Q39002132 | Update on Lupus Nephritis |
| Q38258871 | Update on belimumab for the management of systemic lupus erythematosus |
| Q50691910 | [Systemic lupus erythematosus in Martinique: an epidemiologic study]. |
Search more.